TABLE 3.
Medicines (n = 131) Involved in All Error Cases (n = 58) According to Level 2–3 ATC Codes45
| ATC Group | n (%) | Specific Effective Substance Mentioned in >1 Error Case (n of the Cases) |
|---|---|---|
| B01 Antithrombotic agents | 17 (13.0) | Enoxaparin (7), warfarin (4), acetylsalicylic acid (3) |
| N02A Opioids | 10 (7.6) | Oxycodone (7), fentanyl (2) |
| N05A Antipsychotics | 10 (7.6) | Quetiapine (4), haloperidol (3) |
| A10 Drugs used in diabetes | 8 (6.1) | Metformin (3) |
| C01 Cardiac therapy | 8 (6.1) | Isosorbide mononitrate (2), isosorbide dinitrate (2), digoxin (2) |
| N05C Hypnotics and sedatives | 7 (5.3) | Temazepam (4) |
| N05B Anxiolytics | 6 (4.6) | Diazepam (3), lorazepam (2) |
| C03 Diuretics | 5 (3.8) | Furosemide (5) |
| C07 β-blocking agents | 5 (3.8) | Metoprolol (3), bisoprolol (2) |
| N03 Antiepileptics | 5 (3.8) | — |
| A12AX Calcium, combinations | 4 (3.1) | Calcium and vitamin D combination (4) |
| J01 Antibacterials for systemic use | 4 (3.1) | — |
| R03 Drugs for obstructive airway diseases | 4 (3.1) | — |
| H03 Thyroid therapy | 3 (2.3) | Levothyroxine (3) |
| A06 Drugs for constipation | 3 (2.3) | — |
| N01 Anesthetics | 3 (2.3) | — |
| N06D Antidementia drugs | 3 (2.3) | — |
| V03 All other therapeutic subgroups | 3 (2.3) | Naloxone (3) |
| A02 Drugs for acid related disorders | 2 (1.5) | — |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents | 2 (1.5) | — |
| H02 Corticosteroids for systemic use | 2 (1.5) | — |
| N02B Other analgesics and antipyretics | 2 (1.5) | Paracetamol (2) |
| N06A Antidepressants | 2 (1.5) | — |
| S01 Ophthalmologicals | 2 (1.5) | — |
| Other | 11 (8.4) | — |
| Total | 131 |
Only medicines mentioned in >1 error cases are presented according to specific effective substances.